Lisinopril vs Tofacitinib

## Lisinopril vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Lisinopril** and **Tofacitinib**.

## Mechanism of Action

**Lisinopril**: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Lisinopril — 12 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Lisinopril — C21H31N3O5; Tofacitinib — C16H20N6O.

**Molecular Weight**: Lisinopril — 405.4900 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Lisinopril — Small molecule; Tofacitinib — Small molecule.